Drug delivery gets subcellular

TL;DR - Nature highlights therapies designed to deliver drugs directly to mitochondria and other subcellular organelles, some of which are now entering clinical testing. The provided excerpt does not report specific trial designs or results.

• Organelle-targeted delivery aims to act at disease-relevant sites within cells.
• Mitochondria are a prominent target, alongside other organelles.
• Clinical testing indicates that subcellular drug delivery is moving beyond preclinical research.
• The excerpt provides no efficacy, safety, or patient-outcome data.